Gastrointestinal cytoprotection by prostaglandins.
- 1 January 1979
- Vol. 20 (1) , 75-87
- https://doi.org/10.1136/gut.20.1.75
Abstract
Prostaglandins (PG) are widely distributed throughout the [human, animal] gastrointestinal tract and affect a variety of gastrointestinal functions. The ability of PG to protect the cells of the gastrointestinal epithelium against a variety of potentially noxious agents [nonsteroidal antiinflammatory drugs and other chemicals] which otherwise have the capability of producing cellular damage and necrosis is termed cytoprotection and has been observed with all PG tested, whether or not they possess gastric antisecretory properties. Available evidence suggests that prostaglandins are cyroprotective. The purpose of this discussion is to review the evidence, examine possible mechanisms for this proposed cytoprotective action of PG and suggest clinical situations in which such protection might prove beneficial. Other gastrointestinal actions of PG are discussed only as they relate to cytoprotection.This publication has 108 references indexed in Scilit:
- Indomethacin-induced intestinal inflammationDigestive Diseases and Sciences, 1977
- Double-blind clinical trial on gastroduodenal ulcer healing with prostaglandin E2 analogues.Gut, 1977
- Bile-induced acute erosive gastritisDigestive Diseases and Sciences, 1976
- Effect of gastric secretory inhibitors on the gastric mucosal barrier.Gut, 1975
- Epidermal Synthesis of Prostaglandins and their Effect on Levels of Cyclic Adenosine 3',5'-MonophosphateJournal of Investigative Dermatology, 1975
- Effect of ethanol on permeability and ion transport in the isolated dog stomachDigestive Diseases and Sciences, 1974
- Prevention of Duodenal Ulcers by Administration of Prostaglandin E2(PGE2)Scandinavian Journal of Gastroenterology, 1971
- Release of Prostaglandin E1 from the Rat StomachNature, 1967
- Relationship between aspirin taking and gastroduodenal haemorrhage.Gut, 1967
- Salicylates and Gastro-intestinal BleedingBMJ, 1962